Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response

Eradication of chronic HCV infection: improvement of dysbiosis only in patients without liver cirrhosis

(2021) Freya Wellhöner et al.   HEPATOLOGY

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

(2021) Jason Behary et al.   Nature Communications

Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases

(2021) Chang Liu et al.   FASEB JOURNAL

Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis

(2021) Qiaoyan Liu et al.   GUT

Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection

(2021) Xiu Sun et al.   Hepatology International

TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice

(2020) Mingming Zhao et al.   GASTROENTEROLOGY

Modulation of bile acid profile by gut microbiota in chronic hepatitis B

(2020) Xiaolin Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model

(2020) Xingxing Li et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) Biomarker

(2020) Lina Luo et al.   ANALYTICAL CHEMISTRY

Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health

(2020) Arghya Mukherjee et al.   Gut Microbes

Gut microbiome, liver immunology, and liver diseases

(2020) Rui Wang et al.   Cellular & Molecular Immunology

Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.

(2020) Heather J. Galipeau et al.   GASTROENTEROLOGY

Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

(2020) Antonio Molinaro et al.   Nature Communications

Antibiofilm and antifungal activities of medium‐chain fatty acids against Candida albicans via mimicking of the quorum‐sensing molecule farnesol

(2020) Jin‐Hyung Lee et al.   Microbial Biotechnology

Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma

(2019) Qisha Liu et al.   Gut Pathogens

Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis

(2019) Margherita T. Cantorna et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Community ecology as a framework for human microbiome research

(2019) Jack A. Gilbert et al.   NATURE MEDICINE

Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level

(2019) Yeojun Yun et al.   Journal of Clinical Medicine

Blood metabolome predicts gut microbiome α-diversity in humans

(2019) Tomasz Wilmanski et al.   NATURE BIOTECHNOLOGY

Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma

(2019) Yongbin Zeng et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice

(2019) Qingfeng Zhu et al.   Frontiers in Cellular and Infection Microbiology

Chronic Hepatitis B Infection

(2018) Lydia S. Y. Tang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease

(2018) Huikuan Chu et al.   GUT

The changing epidemiology of liver diseases in the Asia–Pacific region

(2018) Martin C. S. Wong et al.   Nature Reviews Gastroenterology & Hepatology

Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis

(2018) Mingming Sun et al.   Nature Communications

Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1

(2018) Ara Koh et al.   CELL

Type 3 innate lymphoid cell: a new player in liver fibrosis progression

(2018) Siqi Wang et al.   CLINICAL SCIENCE

Synergistic Effect of Quinic Acid Derived From Syzygium cumini and Undecanoic Acid Against Candida spp. Biofilm and Virulence

(2018) Subramanian Muthamil et al.   Frontiers in Microbiology

Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy

(2017) Yan-Dan Ren et al.   HEPATOLOGY

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment

(2017) Yameng Sun et al.   HEPATOLOGY

The Screening of Anticholinergic Accumulation by Traditional Chinese Medicine

(2017) Ming Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

(2017) Wei Jia et al.   Nature Reviews Gastroenterology & Hepatology

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

(2017) Egle Cekanaviciute et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients

(2017) Jing Wang et al.   Frontiers in Microbiology

Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis

(2017) Feliciano Chanana Paquissi   Frontiers in Immunology

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

(2016) Ara Koh et al.   CELL

Adaptive immunity in HBV infection

(2016) Antonio Bertoletti et al.   JOURNAL OF HEPATOLOGY

The Human Intestinal Microbiome in Health and Disease

(2016) Susan V. Lynch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diet- and Genetically-induced Obesity Produces Alterations in the Microbiome, Inflammation and Wnt Pathway in the Intestine of Apc+/1638N Mice: Comparisons and Contrasts

(2016) Wei Liu et al.   Journal of Cancer

An in vitro metabolomics approach to identify hepatotoxicity biomarkers in human L02 liver cells treated with pekinenal, a natural compound

(2015) Jiexia Shi et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B

(2015) Henry Lik-Yuen Chan et al.   JOURNAL OF HEPATOLOGY

Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota

(2015) Han-Hsuan Chou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-17A Enhances the Expression of Profibrotic Genes through Upregulation of the TGF-β Receptor on Hepatic Stellate Cells in a JNK-Dependent Manner

(2014) Thomas Fabre et al.   JOURNAL OF IMMUNOLOGY

Telbivudine therapy may shape CD4+T-cell response to prevent liver fibrosis in patients with chronic hepatitis B

(2014) Jing Li et al.   LIVER INTERNATIONAL

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

(2013) Grace Lai-Hung Wong et al.   HEPATOLOGY

Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance

(2013) Peixiang Lan et al.   HEPATOLOGY

IL-17A Plays a Critical Role in the Pathogenesis of Liver Fibrosis through Hepatic Stellate Cell Activation

(2013) Z. Tan et al.   JOURNAL OF IMMUNOLOGY

Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice

(2012) Fanli Meng et al.   GASTROENTEROLOGY

IL-17 and TNF-  Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial Activation

(2012) G. K. Griffin et al.   JOURNAL OF IMMUNOLOGY

Significance of the Balance between Regulatory T (Treg) and T Helper 17 (Th17) Cells during Hepatitis B Virus Related Liver Fibrosis

(2012) Jing Li et al.   PLoS One

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B

(2010) Yufu Ye et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

(2010) J. L. Round et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA